Arterial Stiffness Increases Over Time in Relation to Lung Diffusion Capacity: A Longitudinal Observation Study in COPD
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 177-187
- https://doi.org/10.2147/COPD.S234882
Abstract
Background: Cardiovascular events are, after cancer, the most common cause of death in COPD patients. Arterial stiffness is an independent predictor of all-cause mortality and cardiovascular events. Several cross-sectional studies have confirmed increased arterial stiffness in patients with COPD. Various mechanisms in the development of arterial stiffness in COPD such as reduced lung function or systemic inflammation have been proposed. However, clinical predictors of arterial stiffness that had been reported in cross-sectional studies have not yet been confirmed in a longitudinal setting. We have assessed the course of augmentation index (AIx) - a measure of systemic arterial stiffness - and possible predictors in a cohort of COPD patients over a period of up to 7 years. Methods: COPD patients underwent annual AIx measurement by applanation tonometry for a maximum duration of 7 years. Additionally, we performed annual assessments of lung function, blood gases, systemic inflammation, serum lipids and blood pressure. Associations between the course of AIx and potential predictors were investigated through a mixed effect model. Results: Seventy-six patients (mean (SD) age 62.4 (7.1), male 67%) were included. The AIx showed a significant annual increase of 0.91% (95% CI 0.21/1.60) adjusted for baseline. The change in diffusion capacity (DLco), low-density lipoprotein (LDL), and high-sensitivity c-reactive protein (hsCRP) was independently associated with the increasing evolution of AIx (Coef. - 0.10, p< 0.001, Coef. 1.37, p=0.003, and Coef. 0.07, p=0.033, respectively). Conclusion: This study demonstrated a meaningful increase in arterial stiffness in COPD over time. A greater annual increase in arterial stiffness was associated with the severity of emphysema (measured by DLco), systemic inflammation, and dyslipidaemia. Clinical Trial Registration: www.ClinicalTrials.gov, NCT01527773.This publication has 39 references indexed in Scilit:
- Soluble TNF and IL-6 receptors: Indicators of vascular health in women without cardiovascular diseaseVascular Medicine, 2013
- Arterial Stiffness Measured Via Carotid Femoral Pulse Wave Velocity Is Associated With Disease Severity in COPDRespiratory Care, 2013
- Relation Between COPD Severity and Global Cardiovascular Risk in US AdultsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung StudyEuropean Respiratory Journal, 2011
- Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPDRespiratory Medicine, 2011
- Association of serum lipids with arterial stiffness in a population-based study in BeijingEuropean Journal of Clinical Investigation, 2011
- Mortality in COPD: Causes, Risk Factors, and PreventionCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Aging and Arterial StiffnessCirculation Journal, 2010
- Arterial Stiffness Is Independently Associated with Emphysema Severity in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Mechanisms, Pathophysiology, and Therapy of Arterial StiffnessArteriosclerosis, Thrombosis, and Vascular Biology, 2005